Laboratorio Clinico Corozal Inc

CLIA Laboratory Citation Details

2
Total Citations
10
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 40D0658073
Address 16 Gandara St, Corozal, PR, 00783
City Corozal
State PR
Zip Code00783
Phone(787) 859-2465

Citation History (2 surveys)

Survey - August 5, 2021

Survey Type: Special

Survey Event ID: SH2W11

Deficiency Tags: D3009

Summary:

Summary Statement of Deficiencies D0000 The laboratorio Clnico Corozal Inc, was found to be in substantial compliance with CLIA regulations (42 CFR Part 493, effective April 24, 2003). No deficiencies were cited as a result of an onsite survey performed on August 5, 2021. D3009 FACILITIES CFR(s): 493.1101(c) The laboratory must be in compliance with applicable Federal, State, and local laboratory requirements. This STANDARD is not met as evidenced by: Based on Covid-19 report records review and general supervisor interview on August 5, 2021 at 11:25 AM, it was determined that the laboratory failed to report the Covid- 19 results as required for 24 out of 47 days reviewed from April 1, 2021 to July 24, 2021. The findings include: 1. The laboratory utilized the Health Department instruction to send the Covid-19 results to the Bioportal. 2. The laboratory processed the Covid-19 test by the following methods: Rapid test Healgen, Covid-19 Antigen and Covid-19 molecular by ID Now. 3. On August 5, 2021 at 11:25 AM, the Covid- 19 rapid report records showed that the laboratory did not send the Covid-19 results in the required frequency (24 hrs) to the Bioportal in 15 out of 36 days reviewed from April 1, 2021 to July 16, 2021: Date Patients Date tested specimens reports tested sent 04/01/2021 1 04/08/2021 04/06/2021 3 04/08/2021 04/12/2021 4 04/14/2021 04/15 /2021 3 04/19/2021 04/16/2021 2 04/19/2021 04/20/2021 1 04/22/2021 05/04/2021 2 05/06/2021 05/10/2021 1 05/12/2021 05/13/2021 1 05/15/2021 05/22/2021 1 05/27 /2021 05/29/2021 2 06/01/2021 06/05/2021 1 06/07/2021 07/03/2021 1 07/06/2021 07 /10/2021 1 07/12/2021 07/16/2021 2 07/19/2021 4. On August 5, 2021 at 11:25 AM, the Covid-19 antigen report records showed that the laboratory did not send the Covid- 19 results in the required frequency (24 hrs) to the Bioportal in 5 out of 5 days reviewed from July 16, 2021 to July 24, 2021: 07/16/2021 1 07/19/2021 07/17/2021 1 07/19/2021 07/21/2021 2 07/27/2021 07/23/2021 5 07/27/2021 07/24/2021 4 07/27 Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- /2021 5. On August 5, 2021 at 11:25 AM, the Covid-19 molecular ( ID Now method) records showed that the laboratory did not send the Covid-19 results in the required frequency (24 hrs) to the Bioportal in 4 out of 6 days reviewed from July 16, 2021 to July 24, 2021: 07/16/2021 4 07/19/2021 07/21/2021 2 07/23/2021 07/23/2021 1 07/27 /2021 07/24/2021 4 07/27/2021 6. The general supervisor confirmed on August 5, 2021 at 11:25 AM, that the laboratory did not send those Covid-19 results in the required frequency (24 hrs) to the Bioportal. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - June 27, 2019

Survey Type: Standard

Survey Event ID: MRRC11

Deficiency Tags: D5421 D5401 D6106 D6106 D6093 D6093 D6144 D5421 D6144

Summary:

Summary Statement of Deficiencies D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on lack of Bacteriology manual, direct observation, bacteriology testing records (year 2019) and bacteriology incubator temperature chart (years 2018 and 2019) review and general supervisor interview on June 27, 2019 at 12:20 PM, it was determined that the laboratory failed to have the procedures manuals for the Bacteriology tests since July, 2017. The findings include: 1. The laboratory did not have available the procedures manual for the Bacteriology area. 2. The bacteriology testing records showed that the laboratory processed patient's urine cultures and reported the no growth and the colony count results in 48 hrs since year 2017. 3. On June 27, 2019 at 12:20 PM, it is observed and by interview with the general supervisor, that the laboratory processed patient's urine cultures with an sterile loops and streaks it across the MacConkey and blood agar culture plate media for the bacterial growth. The streaked plates were covered and incubated. 4. The bacteriology incubator temperature chart includes a temperature range of 35 C +/ - 1 C. The incubator temperature charts showed temperatures results of 35 C during the years 2018 and 2019. No pertinent reference about the incubator temperature range was found. 5. The general supervisor confirmed on June 27, 2019 at 12:20 PM, that the procedures manual for the Bacteriology area was not available. 6. The laboratory processed 1,177 patient's urine cultures from January 2, 2019 to June 27, 2019. D5421 ESTABLISHMENT AND VERIFICATION OF PERFORMANCE CFR(s): 493.1253(b)(1) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- Each laboratory that introduces an unmodified, FDA-cleared or approved test system must do the following before reporting patient test results: (1)(i) Demonstrate that it can obtain performance specifications comparable to those established by the manufacturer for the following performance characteristics: (1)(i)(A) Accuracy. (1)(i) (B) Precision. (1)(i)(C) Reportable range of test results for the test system. (1)(ii) Verify that the manufacturer's reference intervals (normal values) are appropriate for the laboratory's patient population. This STANDARD is not met as evidenced by: Based on review of validation records of the Mindray system for complete cell count (CBC) test and general supervisor interview on June 27, 2019 at 11:00 AM, it was determined that the laboratory failed to complete the evaluation of the performance specifications of this new instruments on February 19, 2019, before processing and reporting 1,870 out of 1,870 patient's CBC specimens results from March 1, 2019 to June 27, 2019. The findings include: 1. On June 27, 2019 at 11:00 AM, the Mindray system validation records showed that the laboratory performed the validation of this instrument on February 19, 2019. However, the laboratory did not include the verification of the CBC reference intervals (normal values) in this validation procedure. 2. The laboratory includes the normal values of the former laboratory CBC's system (CellDyn 3200) in the CBC results reported by the Mindray system from March 1, 2019 to June 27, 2019. 3. The general supervisor confirmed on on June 27, 2019 at 11:00 AM, that the laboratory includes the normal values of the former laboratory CBC's system (CellDyn 3200) in the CBC results reported by the Mindray system from March 1, 2019 to June 27, 2019. She stated, that the laboratory is working to verify the normal range of the CBC tests reported by the Mandry system. 4. The laboratory processed and reported 1,870 out of 1,870 patient's CBC specimens results by the Mindray system from March 1, 2019 to June 27, 2019. D6093 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(5) The laboratory director must ensure that the quality control programs are established and maintained to assure the quality of laboratory services provided and to identify failures in quality as they occur. This STANDARD is not met as evidenced by: Based on review of validation records of the Mindray system for complete cell count (CBC) test and general supervisor interview on June 27, 2019 at 11:00 AM, it was determined that the laboratory failed to complete the evaluation of the performance specifications of this new instruments on February 19, 2019, before processing and reporting 1,870 out of 1,870 patient's CBC specimens results by the Mindray system from March 1, 2019 to June 27, 2019. Refer to D 5421. D6106 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(14) The laboratory director must ensure that an approved procedure manual is available to all personnel responsible for any aspect of the testing process. -- 2 of 3 -- This STANDARD is not met as evidenced by: Based on lack of Bacteriology manual and general supervisor interview on June 27, 2019 at 12:20 PM, it was determined that the laboratory director failed to ensure that an approved procedure manual for bacteriology procedures is available to all personnel responsible for any aspect of the testing process in the bacteriology and hematology areas since July, 2017. Refer to D 5401. D6144 GENERAL SUPERVISOR RESPONSIBILITIES CFR(s): 493.1463 The general supervisor is responsible for day-to-day supervision or oversight of the laboratory operation and personnel performing testing and reporting test results. This STANDARD is not met as evidenced by: Based on review of validation records of the Mindray system for CBC test and general supervisor interview on June 27, 2019 at 11:00 AM, it was determined that the general supervisor failed to perform day-to-day supervision for the personnel that performing the CBC since March 1, 2019. Refer to D 5421 (The laboratory did not complete the evaluation of the performance specifications of the new CBC system before processing and reporting 1,870 out of 1,870 patient's CBC specimens results by the Mindray system from March 1, 2019 to June 27, 2019). -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access